financetom
Business
financetom
/
Business
/
Unilever Q2 Turnover Falls, Underlying Sales Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Unilever Q2 Turnover Falls, Underlying Sales Rise
Jul 31, 2025 2:40 AM

05:25 AM EDT, 07/31/2025 (MT Newswires) -- Unilever ( UL ) reported a Q2 turnover Thursday of 15.34 billion euros ($17.58 billion), down from 16.09 billion euros a year earlier.

Analysts polled by FactSet expected 15.81 billion euros.

Underlying sales for the quarter grew by 3.8%.

Unilever ( UL ) reiterated its 2025 underlying sales growth forecast of 3% to 5%.

The company's shares were up 1.2% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer Unusual Options Activity For June 03
Pfizer Unusual Options Activity For June 03
Jun 3, 2024
Investors with a lot of money to spend have taken a bullish stance on Pfizer ( PFE ) . And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big...
BMO Tweaks Dollarama Estimate Ahead of Q1, Says Near-Term Valuation Elevated
BMO Tweaks Dollarama Estimate Ahead of Q1, Says Near-Term Valuation Elevated
Jun 3, 2024
02:00 PM EDT, 06/03/2024 (MT Newswires) -- Dollarama ( DLMAF ) reports first quarter results on June 12 before market. BMO has lowered its first quarter SSS to 6% from 7% (Street 5.6%) after considering the possibility that more normalization may have occurred than previously assumed. EPS estimate is unchanged at $0.75 (in line with Street). According to analyst Tamy...
Optimi Health Up 12% After Reporting Drug Establishment License From Health Canada
Optimi Health Up 12% After Reporting Drug Establishment License From Health Canada
Jun 3, 2024
02:07 PM EDT, 06/03/2024 (MT Newswires) -- Optimi Health ( OPTHF ) , a licensed psychedelics pharmaceutical manufacturer specializing in controlled substances, was last seen up 12% after the company on Monday said Health Canada awarded the company a Drug Establishment Licence to manufacture and sell its MDMA and psilocybin capsules. The designation affirmed a compliant rating for Good Manufacturing...
Update: Science Applications International Shares Fall After Lower Fiscal Q1 Adjusted Earnings, Revenue; Fiscal 2025 Guidance Reiterated
Update: Science Applications International Shares Fall After Lower Fiscal Q1 Adjusted Earnings, Revenue; Fiscal 2025 Guidance Reiterated
Jun 3, 2024
02:02 PM EDT, 06/03/2024 (MT Newswires) -- (Updates with the latest stock movement in the headline and the first paragraph.) Science Applications International ( SAIC ) shares fell nearly 11% in recent Monday trading after reporting lower fiscal Q1 adjusted earnings and revenue. The company reported fiscal Q1 adjusted earnings of $1.92 per diluted share, down from $2.14 a year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved